Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities

Supplemental Digital Content is available in the text. Background and Purpose: Periventricular white matter hyperintensities (WMH; PVWMH) and deep WMH (DWMH) are regional classifications of WMH and reflect proposed differences in cause. In the first study, to date, we undertook genome-wide association analyses of DWMH and PVWMH to show that these phenotypes have different genetic underpinnings. Methods: Participants were aged 45 years and older, free of stroke and dementia. We conducted genome-wide association analyses of PVWMH and DWMH in 26,654 participants from CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology), ENIGMA (Enhancing Neuro-Imaging Genetics Through Meta-Analysis), and the UKB (UK Biobank). Regional correlations were investigated using the genome-wide association analyses -pairwise method. Cross-trait genetic correlations between PVWMH, DWMH, stroke, and dementia were estimated using LDSC. Results: In the discovery and replication analysis, for PVWMH only, we found associations on chromosomes 2 (NBEAL), 10q23.1 (TSPAN14/FAM231A), and 10q24.33 (SH3PXD2A). In the much larger combined meta-analysis of all cohorts, we identified ten significant regions for PVWMH: chromosomes 2 (3 regions), 6, 7, 10 (2 regions), 13, 16, and 17q23.1. New loci of interest include 7q36.1 (NOS3) and 16q24.2. In both the discovery/replication and combined analysis, we found genome-wide significant associations for the 17q25.1 locus for both DWMH and PVWMH. Using gene-based association analysis, 19 genes across all regions were identified for PVWMH only, including the new genes: CALCRL (2q32.1), KLHL24 (3q27.1), VCAN (5q27.1), and POLR2F (22q13.1). Thirteen genes in the 17q25.1 locus were significant for both phenotypes. More extensive genetic correlations were observed for PVWMH with small vessel ischemic stroke. There were no associations with dementia for either phenotype. Conclusions: Our study confirms these phenotypes have distinct and also shared genetic architectures. Genetic analyses indicated PVWMH was more associated with ischemic stroke whilst DWMH loci were implicated in vascular, astrocyte, and neuronal function. Our study confirms these phenotypes are distinct neuroimaging classifications and identifies new candidate genes associated with PVWMH only.

[1]  J. Ikeda,et al.  Cyclin-dependent kinases as a therapeutic target for stroke. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Hofman,et al.  Silent Brain Infarcts and White Matter Lesions Increase Stroke Risk in the General Population: The Rotterdam Scan Study , 2003, Stroke.

[3]  Benjamin F. J. Verhaaren,et al.  Replication Study of Chr17q25 With Cerebral White Matter Lesion Volume , 2011, Stroke.

[4]  S. Scherer,et al.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.

[5]  B. Bein,et al.  Remote ischemic preconditioning regulates HIF-1α levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study , 2012, Basic Research in Cardiology.

[6]  S. Greenberg,et al.  COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. , 2012, American journal of human genetics.

[7]  Westgate Road,et al.  Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study. , 2006 .

[8]  J. Reuck,et al.  The Human Periventricular Arterial Blood Supply and the Anatomy of Cerebral Infarctions , 1971 .

[9]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[10]  C. Sudlow,et al.  Genetic variation at 16q24.2 is associated with small vessel stroke , 2017, Annals of neurology.

[11]  S. Hadano,et al.  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.

[12]  Lorna M. Lopez,et al.  Multiethnic Genome-Wide Association Study of Cerebral White Matter Hyperintensities on MRI , 2015, Circulation. Cardiovascular genetics.

[13]  Y. Kuang,et al.  Impact of interaction between the G870A and EFEMP1 gene polymorphism on glioma risk in Chinese Han population , 2017, Oncotarget.

[14]  F. Fazekas,et al.  Pathologic correlates of incidental MRI white matter signal hyperintensities , 1993, Neurology.

[15]  J. O'Brien,et al.  White Matter Lesions in an Unselected Cohort of the Elderly: Molecular Pathology Suggests Origin From Chronic Hypoperfusion Injury , 2006, Stroke.

[16]  Wei Wen,et al.  White matter hyperintensities in mid-adult life , 2008, Current opinion in psychiatry.

[17]  M. Dichgans,et al.  Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging , 2013, The Lancet Neurology.

[18]  Heping Gu,et al.  The association between an endothelial nitric oxide synthase gene polymorphism and coronary heart disease in young people and the underlying mechanism. , 2017, Molecular medicine reports.

[19]  Michael E. Greenberg,et al.  A Calcium-Responsive Transcription Factor, CaRF, that Regulates Neuronal Activity-Dependent Expression of BDNF , 2002, Neuron.

[20]  C. Labelle-Dumais,et al.  COL4A1 and COL4A2 mutations and disease: insights into pathogenic mechanisms and potential therapeutic targets , 2012, Human molecular genetics.

[21]  Anbupalam Thalamuthu,et al.  White Matter Hyperintensities Are Under Strong Genetic Influence , 2016, Stroke.

[22]  Bogdan Pasaniuc,et al.  Local genetic correlation gives insights into the shared genetic architecture of complex traits , 2016, bioRxiv.

[23]  C. Jack,et al.  Blood Pressure and White-Matter Disease Progression in a Biethnic Cohort: Atherosclerosis Risk in Communities (ARIC) Study , 2010, Stroke.

[24]  Nicholette D. Palmer,et al.  Exome Chip Analysis Identifies Low-Frequency and Rare Variants in MRPL38 for White Matter Hyperintensities on Brain Magnetic Resonance Imaging , 2018, Stroke.

[25]  K. Kadler,et al.  Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke , 2013, Human molecular genetics.

[26]  M. Fornage,et al.  Genome‐wide association studies of cerebral white matter lesion burden , 2011, Annals of neurology.

[27]  Ludovica Griffanti,et al.  Classification and characterization of periventricular and deep white matter hyperintensities on MRI: A study in older adults , 2017, NeuroImage.

[28]  Rajendra K. Sharma,et al.  Expression of N-myristoyltransferase in Human Brain Tumors , 2004, Neurochemical Research.

[29]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[30]  Jie Huang,et al.  Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function , 2017, The Journal of clinical investigation.

[31]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[32]  C. Sudlow,et al.  Enlarged perivascular spaces and cerebral small vessel disease , 2013, International journal of stroke : official journal of the International Stroke Society.

[33]  M. Dichgans,et al.  Genetic Study of White Matter Integrity in UK Biobank (N=8448) and the Overlap With Stroke, Depression, and Dementia , 2018, Stroke.

[34]  C. Sudlow,et al.  Genetic variation in PLEKHG1 is associated with white matter hyperintensities (n = 11,226) , 2019, Neurology.

[35]  Gunhild Waldemar,et al.  Deterioration of Gait and Balance over Time: The Effects of Age-Related White Matter Change - The LADIS Study , 2013, Cerebrovascular Diseases.

[36]  Hui Zhang,et al.  White matter microstructure pathology in classic galactosemia revealed by neurite orientation dispersion and density imaging , 2014, Journal of Inherited Metabolic Disease.

[37]  C. Sudlow,et al.  Genome‐wide meta‐analysis identifies 3 novel loci associated with stroke , 2018, Annals of neurology.

[38]  L. McEvoy,et al.  White matter disease in midlife is heritable, related to hypertension, and shares some genetic influence with systolic blood pressure , 2016, NeuroImage: Clinical.

[39]  Kaitlin M. Fitzpatrick,et al.  Genome-wide meta-analysis of cerebral white matter hyperintensities in patients with stroke , 2016, Neurology.

[40]  Anne Corbett,et al.  Depression and dementia. , 2011, Mental health today.

[41]  M. Bojar.  DEPARTMENT OF NEUROLOGY , 1923 .

[42]  Philip Scheltens,et al.  Relationship between periventricular and deep white matter lesions and depressive symptoms in older people. The LADIS Study , 2006, International journal of geriatric psychiatry.

[43]  C. Boucheix,et al.  Regulation of the trafficking and the function of the metalloprotease ADAM10 by tetraspanins. , 2017, Biochemical Society transactions.

[44]  Lisa J. Martin,et al.  Common variation in COL4A1/COL4A2 is associated with sporadic cerebral small vessel disease , 2015, Neurology.

[45]  C. Sudlow,et al.  COL4A2 is associated with lacunar ischemic stroke and deep ICH: Meta-analyses among 21,500 cases and 40,600 controls , 2017, Neurology.

[46]  Lisa J. Martin,et al.  Common variation in COL 4 A 1 / COL 4 A 2 is associated with sporadic cerebral small vessel disease , 2022 .

[47]  A. Hofman,et al.  Silent brain infarcts and the risk of dementia and cognitive decline. , 2003, The New England journal of medicine.

[48]  W. M. van der Flier,et al.  Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[49]  Joseph K. Pickrell,et al.  Detection and interpretation of shared genetic influences on 42 human traits , 2015, Nature Genetics.

[50]  C. Has.  The "Kelch" Surprise: KLHL24, a New Player in the Pathogenesis of Skin Fragility. , 2017, The Journal of investigative dermatology.

[51]  Lucas O. Müller,et al.  Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease , 2017, Stroke and Vascular Neurology.

[52]  C. Lewis,et al.  Genetic discovery in multi-ethnic populations , 2016, European Journal of Human Genetics.

[53]  Nick C Fox,et al.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration , 2013, The Lancet Neurology.

[54]  J. Dudink,et al.  COL4A2 mutation associated with familial porencephaly and small-vessel disease , 2012, European Journal of Human Genetics.

[55]  Chinthasagar Bastian,et al.  NOS3 Inhibition Confers Post-Ischemic Protection to Young and Aging White Matter Integrity by Conserving Mitochondrial Dynamics and Miro-2 Levels , 2018, The Journal of Neuroscience.